Dr. Ahou Meydani-Korb, MD

Dr. Meydani-Korb practices at CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance.

Dr. Meydani-Korb's NPI, 1487811147, was assigned on May 20, 2008. Dr. Meydani-Korb graduated from Yale University School of Medicine in 2007. Dr. Meydani-Korb holds New York license 262383.

Dr. Meydani-Korb's primary practice is CHA Cambridge Hospital, at 1493 Cambridge Street, Cambridge, MA 02139 in Middlesex County. The practice phone is (617) 665-1000.

Dr. Meydani-Korb's primary practice is CHA Cambridge Hospital in Cambridge, Massachusetts, part of Cambridge Health Alliance. The medical group on file is Cambridge Health Alliance. Dmand AI also links Dr. Meydani-Korb to 1 more group practice or clinic, named with a free account. Dr. Meydani-Korb's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Meydani-Korb practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Meydani-Korb's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Meydani-Korb is licensed in New York.

CMS data shows 388 Medicare services from Dr. Meydani-Korb across 8 procedure codes in 2024, for 172 Medicare patients. Medicare paid $15,685 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 172 Medicare patients who saw Dr. Meydani-Korb in 2024. The largest group is 65 to 74, with 80 patients. 58% of them have high blood pressure, and 40% have high cholesterol. 50% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Meydani-Korb's median patient age at 46, with 60% women.

In 2024, Dr. Meydani-Korb wrote 462 Medicare Part D claims for 152 patients. 77% of them were for generic drugs. CMS names the drug for 347 of them, across 18 drugs with 11 or more claims each, at $97,723 in total drug cost. In 2023, CMS named 227 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Meydani-Korb for performance year 2024, reported as part of a group. Dr. Meydani-Korb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 126 procedures of removal of skin lesions by Dr. Meydani-Korb, more than 76% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Meydani-Korb in 2020. Dr. Meydani-Korb's most frequent co-author is Jessamyn Blau, MD.

CMS Open Payments shows 2 general payments to Dr. Meydani-Korb from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $38.

Dr. Meydani-Korb graduated from Yale University School of Medicine in 2007.